COVID-19 antibodies persist, reduce reinfection risk for up to six months, study finds

ScienceDaily
Sep 14, 2021, 6:48 pm468 ptsHot
Most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months, a new study found. The antibodies' ability to neutralize COVID-19 did not differ significantly from the first visit, which occurred three months after infection, to the second…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

150 New Fast EV Chargers To Use 100% Renewable Energy 129

Xpeng VLA 2.0 test drive: Tesla is not alone with ‘Full Self-Driving’ anymore 127

Hydrogen Fuel Cell Cars No; Fuel Cell Combat Drones Yes 124

Volkswagen opens ID. Polo orders at $40,000, but a more affordable model is coming 122

Here’s our first look at the Hyundai IONIQ 3 standard version [Video] 121

Chinese Brands Project Confidence at the Beijing Auto Show: Large Premium SUVs (Gallery) 119

Webinar: Prenatal exposure to organophosphate pesticides: health outcomes & potential mechanisms 117

Marine resource conflicts in Africa revolve mostly around access: Study 113

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.